Veerhealth Care Limited (BOM:511523)
India · Delayed Price · Currency is INR 49.58
+0.19 (0.38%)
At close: Sep 30, 2026
Veerhealth Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 529.25 | 324.84 | 168.67 | 132.23 | 132.73 | 96.26 |
Other Revenue | 3.12 | - | - | 9.9 | 9.41 | 11.73 |
| 532.37 | 324.84 | 168.67 | 142.13 | 142.14 | 107.99 | |
Revenue Growth | 158.40% | 92.60% | 18.67% | -0.00% | 31.62% | -5.02% |
Cost of Revenue | 409.76 | 243.17 | 115.83 | 92.56 | 94.75 | 71.27 |
Gross Profit | 122.61 | 81.68 | 52.83 | 49.57 | 47.39 | 36.73 |
Selling, General & Admin | 19.36 | 19.29 | 17.04 | 15.38 | 12.87 | 11.79 |
Other Operating Expenses | 56.1 | 36.39 | 26.86 | 18.2 | 20.14 | 21.41 |
Operating Expenses | 89.18 | 68.6 | 52.98 | 40.69 | 39.22 | 38.44 |
Operating Income | 33.44 | 13.08 | -0.15 | 8.88 | 8.17 | -1.72 |
Interest Expense | -5.4 | -3.7 | -0.9 | - | - | -0.45 |
Interest & Investment Income | - | 5.85 | 7.68 | 3.99 | 2.99 | 4.94 |
Other Non Operating Income (Expenses) | - | 0.44 | -0.42 | -0.08 | -0.01 | -0.41 |
EBT Excluding Unusual Items | 28.04 | 15.68 | 6.21 | 12.8 | 11.14 | 2.38 |
Gain (Loss) on Sale of Assets | - | - | - | 0.02 | 0.03 | - |
Other Unusual Items | -3.1 | -3.1 | - | - | - | - |
Pretax Income | 24.94 | 12.58 | 6.21 | 12.82 | 11.17 | 2.38 |
Income Tax Expense | 9.64 | 7.14 | 2.3 | 8.75 | -4.65 | 3.11 |
Net Income | 15.3 | 5.44 | 3.91 | 4.06 | 15.82 | -0.74 |
Net Income to Common | 15.3 | 5.44 | 3.91 | 4.06 | 15.82 | -0.74 |
Net Income Growth | 199.65% | 39.01% | -3.63% | -74.33% | - | - |
Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 20 | 14 |
Shares Outstanding (Diluted) | 21 | 20 | 20 | 20 | 20 | 14 |
Shares Change | 5.08% | - | - | - | 44.20% | - |
EPS (Basic) | 0.76 | 0.27 | 0.20 | 0.20 | 0.79 | -0.05 |
EPS (Diluted) | 0.75 | 0.27 | 0.20 | 0.20 | 0.79 | -0.05 |
EPS Growth | 185.17% | 39.01% | -3.63% | -74.33% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -6.64 | -42.98 | 20.7 | -27.85 | 2.25 |
Free Cash Flow Per Share | - | -0.33 | -2.15 | 1.03 | -1.39 | 0.16 |
Gross Margin | 23.03% | 25.14% | 31.32% | 34.88% | 33.34% | 34.01% |
Operating Margin | 6.28% | 4.03% | -0.09% | 6.25% | 5.75% | -1.59% |
Profit Margin | 2.87% | 1.68% | 2.32% | 2.86% | 11.13% | -0.68% |
Free Cash Flow Margin | - | -2.05% | -25.49% | 14.56% | -19.59% | 2.08% |
EBITDA | 47.31 | 25.99 | 8.93 | 16 | 14.39 | 3.53 |
EBITDA Margin | 8.89% | 8.00% | 5.29% | 11.25% | 10.12% | 3.26% |
D&A For EBITDA | 13.87 | 12.91 | 9.08 | 7.12 | 6.22 | 5.24 |
EBIT | 33.44 | 13.08 | -0.15 | 8.88 | 8.17 | -1.72 |
EBIT Margin | 6.28% | 4.03% | -0.09% | 6.25% | 5.75% | -1.59% |
Effective Tax Rate | 38.65% | 56.75% | 36.97% | 68.31% | - | 130.98% |
Revenue as Reported | 532.37 | 332.86 | 178.89 | 146.13 | 145.13 | 112.94 |
Advertising Expenses | - | 2.15 | 1.26 | 2.28 | 3.67 | 2.92 |